Sandbox carlos: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 7: Line 7:
:::* Mild to moderate severity.Preferred regimen: [[Itraconazole]] solution 200 mg po or IV bid {{OR}} [[Fluconazole]] 400 mg po q24h for 3–12 mo
:::* Mild to moderate severity.Preferred regimen: [[Itraconazole]] solution 200 mg po or IV bid {{OR}} [[Fluconazole]] 400 mg po q24h for 3–12 mo
:::* Locally severe or disseminated disease: Amphotericine B 0.6–1 mg/kg per day x 7 days then 0.8 mg/kg every other day or liposomal ampho B 3-5 mg/kg/d IV or ABLC 5 mg/kg/d IV, until clinical improvement (usually several wks or longer in disseminated disease), followed by itra or flu for at least 1 year.
:::* Locally severe or disseminated disease: Amphotericine B 0.6–1 mg/kg per day x 7 days then 0.8 mg/kg every other day or liposomal ampho B 3-5 mg/kg/d IV or ABLC 5 mg/kg/d IV, until clinical improvement (usually several wks or longer in disseminated disease), followed by itra or flu for at least 1 year.
:::Note (1): Some use combination of Ampho B & Flu for progressive severe disease; controlled series lacking.
:::* Note (1): Some use combination of Ampho B & Flu for progressive severe disease; controlled series lacking.
:::Note (2): Consultation with specialist recommendation, surgery may be required.
:::* Note (2): Consultation with specialist recommendation, surgery may be required.


::* '''Meningitis:'''
::* '''Meningitis:'''
Line 14: Line 14:
:::* Preferred regimen: Fluconazole 400–1,000 mg po q24h indefinitely
:::* Preferred regimen: Fluconazole 400–1,000 mg po q24h indefinitely
:::* Alternative regimen: Ampho B IV as for pulmonary (above) + 0.1–0.3 mg daily intrathecal (intraventricular) via reservoir device. OR itra 400–800 mg q24h OR voriconazole
:::* Alternative regimen: Ampho B IV as for pulmonary (above) + 0.1–0.3 mg daily intrathecal (intraventricular) via reservoir device. OR itra 400–800 mg q24h OR voriconazole
:::Note (1): Some use combination of Ampho B & Flu for progressive severe disease; controlled series lacking.
:::* Note (1): Some use combination of Ampho B & Flu for progressive severe disease; controlled series lacking.


:::*'''Child:'''
:::*'''Child:'''
Line 23: Line 23:
::*'''Meningitis AIDS patients'''
::*'''Meningitis AIDS patients'''
:::Preferrered regimen: Induction phase, Amphotericin B 0.7 mg/kg IV + flucytosine 25 mg/kg PO four times a day × 2 wks, then fluconazole 400 mg PO once daily × 8 wks, then 200 mg PO once daily until CD4 >200 × >6 mos.
:::Preferrered regimen: Induction phase, Amphotericin B 0.7 mg/kg IV + flucytosine 25 mg/kg PO four times a day × 2 wks, then fluconazole 400 mg PO once daily × 8 wks, then 200 mg PO once daily until CD4 >200 × >6 mos.
:::Note (1): Monitor 5-FC levels and CBC to avoid bone marrow suppression.
:::* Note (1): Monitor 5-FC levels and CBC to avoid bone marrow suppression.


:::*Alternative regimen: Above without flucytosine, but need to treat for 4-6 wks of ampho B or 12 wks of fluconazole 1200 mg/day (especially if neutropenic).
:::*Alternative regimen: Above without flucytosine, but need to treat for 4-6 wks of ampho B or 12 wks of fluconazole 1200 mg/day (especially if neutropenic).

Revision as of 18:32, 21 July 2015


  • 1.Primary pulmonary infection in patients low risk persistence/complication: Antifungal treatment not generally recommended. Treat fever weight loss and/or fatigue.
  • 1.1 Primary pulmonary infection in patients with increased risk of complications or dissemination:
  • Mild to moderate severity.Preferred regimen: Itraconazole solution 200 mg po or IV bid Template:OR Fluconazole 400 mg po q24h for 3–12 mo
  • Locally severe or disseminated disease: Amphotericine B 0.6–1 mg/kg per day x 7 days then 0.8 mg/kg every other day or liposomal ampho B 3-5 mg/kg/d IV or ABLC 5 mg/kg/d IV, until clinical improvement (usually several wks or longer in disseminated disease), followed by itra or flu for at least 1 year.
  • Note (1): Some use combination of Ampho B & Flu for progressive severe disease; controlled series lacking.
  • Note (2): Consultation with specialist recommendation, surgery may be required.
  • Meningitis:
  • Adult:
  • Preferred regimen: Fluconazole 400–1,000 mg po q24h indefinitely
  • Alternative regimen: Ampho B IV as for pulmonary (above) + 0.1–0.3 mg daily intrathecal (intraventricular) via reservoir device. OR itra 400–800 mg q24h OR voriconazole
  • Note (1): Some use combination of Ampho B & Flu for progressive severe disease; controlled series lacking.
  • Child:
  • Preferred regimen: Fluconazole (po) (Pediatric dose not established, 6 mg per kg q24h used)
  • Alternative regimen: Ampho B IV as for pulmonary (above) + 0.1–0.3 mg daily intrathecal (intraventricular) via reservoir device. OR itra 400–800 mg q24h OR voriconazole


  • Meningitis AIDS patients
Preferrered regimen: Induction phase, Amphotericin B 0.7 mg/kg IV + flucytosine 25 mg/kg PO four times a day × 2 wks, then fluconazole 400 mg PO once daily × 8 wks, then 200 mg PO once daily until CD4 >200 × >6 mos.
  • Note (1): Monitor 5-FC levels and CBC to avoid bone marrow suppression.
  • Alternative regimen: Above without flucytosine, but need to treat for 4-6 wks of ampho B or 12 wks of fluconazole 1200 mg/day (especially if neutropenic).
  • Fluconazole alternative: itraconazole (not as effective). Ampho B alternative liposomal AmB 4-6 mg/kg/day IV.
  • Maintenance phase: fluconazole 200 mg PO once daily life long or discontinue maintenance fluconazole when CD4 >200 × 6 mos and completed 10 wks rx minimum and asymptomatic. CSF pressure OP > 250 mm H2O: remove CSF fluid until pressure drops 50%, then daily LP with same rule until OP <200 mm H2O.




References

Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_carlos&oldid=1119978"